Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Integer Holdings Corp(ITGR)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ITGR
11/13/2026: ITGR (4-star) is a STRONG-BUY. BUY for 124 days. Simulated Profits (38.49%). Updated daily EoD!
Integer Holdings Corp is a prominent medical device outsource manufacturer serving the critical cardiac, neuromodulation, and vascular markets. The company holds a significant position due to its specialized expertise in high-reliability components, which serves as a core competitive advantage. Its primary growth opportunity lies in the long-term trend of OEMs outsourcing manufacturing to reduce costs, alongside expansion into high-growth therapeutic areas like electrophysiology. Key risks include heavy revenue concentration among a small group of major customers and the execution risks inherent in M&A integration. ITGR may best suit growth-oriented investors who are comfortable with the regulatory and operational risks of the medical device manufacturing supply chain.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in the resilient, growing medical technology sector with consistent demand drivers. |
| Momentum investor | Mixed fit | Momentum depends on the stock maintaining upward trends alongside positive earnings momentum. |
| Value investor | Mixed fit | Valuation is often tied to growth expectations, making it less attractive if the growth multiple expands significantly. |
| Dividend investor | Weak fit | The company does not pay a dividend, prioritizing capital reinvestment instead. |
| Low-risk investor | Mixed fit | While the business is durable, medical device manufacturing involves regulatory and customer concentration risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can experience swings based on broader market conditions and medical device sector sentiment. |
| Valuation risk | Medium | Growth expectations are already priced into the shares, limiting margin for error. |
| Competition risk (OEM in-house manufacturing) | Medium / high | OEMs may decide to bring critical manufacturing back in-house to secure supply chains. |
| Business quality | Strong | The company provides essential, hard-to-replicate components for critical medical devices. |
| Dividend income | Low / none | Investors should not rely on ITGR for regular income. |
| Execution risk | Medium | Future growth depends on the successful integration of further acquisitions and capacity expansions. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.30B USD | Price to earnings Ratio 42.48 | 1Y Target Price 127 |
Price to earnings Ratio 42.48 | 1Y Target Price 127 | ||
Volume (30-day avg) 821.0K shares | Beta 0.58 | 52 Weeks Range 66.51 - 126.83 | Updated Date 11/13/2026 |
52 Weeks Range 66.51 - 126.83 | Updated Date 11/13/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.98 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 65.24% | Avg. Invested days 72 | Today’s Advisory Strong Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/13/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Cardiac Rhythm Management | Batteries, capacitors, and lead components for pacemakers and ICDs. | The bread-and-butter of the company, providing stable, long-term revenue from essential medical devices. |
| Neuromodulation | Components for neurostimulation devices used to treat pain and neurological disorders. | A growing segment as more chronic conditions are treated with implantable stimulation technology. |
| Vascular Access | Guidewires, catheters, and sheath systems for vascular procedures. | Highly specialized products that benefit from the global shift toward minimally invasive surgery. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-29 | When Before Market | Estimate 1.65 | Actual 1.34 |
Profitability
Profit Margin 5.68% | Operating Margin (TTM) 9.81% |
Management Effectiveness
Return on Assets (TTM) 3.3% | Return on Equity (TTM) 5.97% |
Valuation
Trailing PE 42.48 | Forward PE 22.52 | Enterprise Value 5.63B | Price to Sales(TTM) 2.36 |
Enterprise Value 5.63B | Price to Sales(TTM) 2.36 | ||
Enterprise Value to Revenue 3.09 | Enterprise Value to EBITDA 20.16 | Shares Outstanding 34.00M | Shares Floating 28.90M |
Shares Outstanding 34.00M | Shares Floating 28.90M | ||
Percent Insiders 0.97 | Percent Institutions 125.72 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.